Patents by Inventor Richard E. Jones

Richard E. Jones has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6171342
    Abstract: A medical fastening system for a modular knee prosthesis system includes a femoral component having a first surface, a second surface, and an aperture extending therebetween. A modular adapter element has a first end that is mountable adjacent the first surface of the femoral component and a second, mating end that is engagable with a second prosthesis component. The system also includes a first bolt that mates the adapter element to the femoral component. Various connection options are possible to secure different components of the system to each other.
    Type: Grant
    Filed: March 30, 1998
    Date of Patent: January 9, 2001
    Assignee: Depuy Orthopaedics, Inc.
    Inventors: Michael J. O'Neil, Arnold Oyola, Dennis Sullivan, Amit Birla, John E. Slamin, Dennis P. Colleran, Stefan M. Gabriel, George B. Cipolletti, Richard E. Jones
  • Patent number: 6077545
    Abstract: An improved diluent for the preparation of cisplatin suspensions from a lyophilized powder is provided. The diluent contains a pharmaceutically acceptable nonionic surfactant, which improves the accuracy and homogeneity of the therapeutic formulation. The suspension may be used directly, or may be used in preparing gel formulations for direct injection into a neoplastic lesion or surrounding tissue.
    Type: Grant
    Filed: October 30, 1995
    Date of Patent: June 20, 2000
    Assignee: Matrix Pharmaceuticals, Inc.
    Inventors: Kathleen V. Roskos, Richard E. Jones, Richard Maskiewicz
  • Patent number: 5980946
    Abstract: Disclosed are proteinaceous compositions comprising collagen and an effective amount of a compatible cytotoxic drug which compositions are characterized by having a single collagen transition temperature of less than about 45.degree. C. Such compositions possess enhanced retention of the cytotoxic drug at the site of injection and are optically translucent.
    Type: Grant
    Filed: September 3, 1997
    Date of Patent: November 9, 1999
    Assignee: Matrix Pharmaceutical, Inc.
    Inventors: Richard E. Jones, Mike T. Li
  • Patent number: 5935679
    Abstract: Conductive and/or chemically absorptive ceramic fibers are woven with optional non-conductive/non-absorptive ceramic fibers to create a fiber reinforcement which is impregnated with a ceramic-material-producing (pre-ceramic polymer) binder and heated to create the ceramic honeycomb with controlled ohmic loss and/or chemical absorption properties. The desired properties of the honeycomb material can be provided by the conductive and/absorptive ceramic fibers alone or in combination with non-fibrous or fibrous conductive and/or absorptive ceramic material provided by the binder, typically a preceramic polymer which may or may not contain dispersed ceramic materials; after the honeycomb is formed, the non-fibrous or fibrous conductive and/or absorptive ceramic material is interspersed throughout the honeycomb. By heating the impregnated fiber reinforcement in the absence of oxygen, carbon from any carbon-containing materials within the binder remain as a part of the honeycomb material.
    Type: Grant
    Filed: June 9, 1997
    Date of Patent: August 10, 1999
    Assignee: Northrop Grumman Corporation
    Inventors: Robert A. Petrisko, Gary Lee Stark, Daniel R. Petrak, Richard E. Jones
  • Patent number: 5874402
    Abstract: Methods are provided for the treatment of a host suffering from a cellular proliferative disease through administration of a chemotherapeutic agent in conjunction with a cell membrane permeant. Optionally, the cell membrane permeant and/or chemotherapeutic agent will be present in a pharmaceutically acceptable vehicle capable of acting as a depot. In the subject methods, the chemotherapeutic agent and membrane permeant are administered at least proximal to a target site of the host. Administration of chemotherapeutic agents in accordance with the subject methods results in improved efficacy of, and/or decreased host toxicity to, the intralesionally administered chemotherapeutic agent.
    Type: Grant
    Filed: May 16, 1997
    Date of Patent: February 23, 1999
    Assignee: Matrix Pharmaceutical, Inc.
    Inventors: Saira Singh, Richard E. Jones, Dennis M. Brown
  • Patent number: 5851403
    Abstract: Conductive and/or chemically absorptive ceramic fibers are woven with optional non-conductive/non-absorptive ceramic fibers to create a fiber reinforcement which is impregnated with a ceramic-material-producing (pre-ceramic polymer) binder and heated to create the ceramic honeycomb with controlled ohmic loss and/or chemical absorption properties. The desired properties of the honeycomb material can be provided by the conductive and/absorptive ceramic fibers alone or in combination with non-fibrous or fibrous conductive and/or absorptive ceramic material provided by the binder, typically a preceramic polymer which may or may not contain dispersed ceramic materials; after the honeycomb is formed, the non-fibrous or fibrous conductive and/or absorptive ceramic material is interspersed throughout the honeycomb. By heating the impregnated fiber reinforcement in the absence of oxygen, carbon from any carbon-containing materials within the binder remain as a part of the honeycomb material.
    Type: Grant
    Filed: June 4, 1997
    Date of Patent: December 22, 1998
    Assignee: Northrop Grumman Corporation
    Inventors: Robert A. Petrisko, Gary Lee Stark, Daniel R. Petrak, Richard E. Jones
  • Patent number: 5750146
    Abstract: Disclosed are translucent proteinaceous compositions comprising collagen and an effective amount of a compatible cytotoxic drug which compositions are characterized by having a single collagen transition temperature of less than about 45.degree. C. Such compositions possess enhanced retention of the cytotoxic drug at the site of injection and are optically translucent.
    Type: Grant
    Filed: April 28, 1995
    Date of Patent: May 12, 1998
    Assignee: Matrix Pharmaceutical, Inc.
    Inventors: Richard E. Jones, Mike T. Li
  • Patent number: 5726421
    Abstract: An ejection system is provided which has a mechanism such as a plunger which is positioned to eject at least a portion of a cigarette from the lighter cavity upon actuation by a smoker. The plunger is also positionable to occlude the lighter opening to protect the lighter cavity from dust, moisture, etc. The plunger is shaped, located and arranged to apply a force on the cigarette end inserted into the lighter. Further, an icon based indicator informs the smoker of the status of a cigarette inserted into the lighter.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: March 10, 1998
    Assignee: Philip Morris Incorporated
    Inventors: Grier S. Fleischhauer, Patrick H. Hayes, Charles T. Higgins, Richard E. Jones, Robert L. Ripley, T. Paul Beane, J. Robert Nelson, Jr.
  • Patent number: 5573781
    Abstract: Methods and compositions are provided for the treatment of a host with a cellular proliferative disease, particularly a neoplasia. In the subject methods, a pharmaceutically acceptable, substantially anhydrous, injectable semi-solid composition which acts as a depot for a cytostatic agent, is administered to a lesion of the disease, particularly intralesionally. The subject compositions comprise a water immiscible, fatty acid ester matrix and a cytostatic agent.
    Type: Grant
    Filed: December 29, 1994
    Date of Patent: November 12, 1996
    Assignee: Matrix Pharmaceutical, Inc.
    Inventors: Dennis M. Brown, Richard E. Jones, Richard Maskiewicz, Shawnya K. Michaels
  • Patent number: 5562964
    Abstract: Improved detaching of perforated roll products of paper or nonwovens is achieved by selectively reducing strength of the sheet along the perforation line at the edges of the sheet. This is achieved by lowering the bonded length (the sum total of the distance between perforations) at the edges of the sheet relative to that within the central portion of the sheets. Greater bonded lengths in the middle of the sheet enable the sheet to pass through converting operations with minimal breaks, while having lower bonded lengths at the outer edges allows the user to more easily start a tear in the sheet at the perf line and reduce the number of "ears" left on the roll as a result of detaching.
    Type: Grant
    Filed: December 14, 1994
    Date of Patent: October 8, 1996
    Assignee: Kimberly-Clark Corporation
    Inventor: Richard E. Jones
  • Patent number: 5279294
    Abstract: Hand-held shirt-pocket portable instrument for quantitative measurement of glucose or analysis in biological fluids. The system accepts a disposable diagnostic reagent test device which has a reagent carrier and mode of identifying to the instrument the reagent lot characteristics. The instrument includes a housing structure having a visual LCD readout, a microprocessor, and photosensing circuitry which measures the change of color of the reagent carrier upon reaction in the reacting chemistry of the disposable test device. The housing also includes a spring arrangement for actuating a disposable lancet into the skin for generating blood. The disposable diagnostic reagent unit includes a configuration for transporting of the blood in the regent unit. The system includes verification and calibration sequences for the electronics, the chemistry of an unused disposable unit, the presence of a blood sample, and the ambient temperature. The system also provides for storing a plurality of analysis readings.
    Type: Grant
    Filed: March 26, 1990
    Date of Patent: January 18, 1994
    Assignee: Cascade Medical, Inc.
    Inventors: Paul J. Anderson, Ross A. Jessen, David R. Linde, Richard E. Jones, Bert Walter, Paul E. Christenson
  • Patent number: 5151265
    Abstract: A liquid pharmaceutical composition comprising an effective amount of non-lyophilized gamma-interferon. The liquid pharmaceutical composition which additionally includes a buffer capable of maintaining the pH of the liquid composition within the range of 4.0 to 6.0, a stabilizing agent and a non-ionic detergent.
    Type: Grant
    Filed: April 25, 1990
    Date of Patent: September 29, 1992
    Assignee: Genentech, Inc.
    Inventors: Jiin-Yu Hwang-Felgner, Richard E. Jones, James F. Maher
  • Patent number: 5135809
    Abstract: The elastic modulus and density of an amorphous, ceramic article derived from a resinous organosilicon polymer and having a composition consisting essentially of silicon, nitrogen and/or carbon are increased while substantially maintaining or improving tensile strength by heat treating the ceramic article at an elevated temperature under superatmospheric nitrogen pressure to increase its density while avoiding crystallization. During heat treatment, at least some of the conditions of time, temperature, heating rate, cooling rate, pressure and atmosphere are controlled to minimize erosion of the article which could otherwise occur due to the loss to the surrounding atmosphere, as a gas or gaseous component, of at least one of nitrogen, silicon and carbon. The heat treated, ceramic article is amorphous and non-crystalline and has a density substantially greater than 2.5 g/cc together with desirable values of tensile strength and elastic modulus.
    Type: Grant
    Filed: September 27, 1989
    Date of Patent: August 4, 1992
    Assignee: Dow Corning Corporation
    Inventors: James A. Rabe, Jonathan Lipowitz, Richard E. Jones
  • Patent number: 5071438
    Abstract: A prosthetic knee with a tibial prosthesis comprising a baseplate and an articulating surface which pivots on the baseplate about an axis within a medial condylar compartment.
    Type: Grant
    Filed: November 7, 1990
    Date of Patent: December 10, 1991
    Assignee: Intermedics Orthopedics, Inc.
    Inventors: Richard E. Jones, Joseph S. Skraba, John D. Vinciguerra
  • Patent number: 4933168
    Abstract: A unique crystalline polymorphic form of flunisolide is disclosed which is stable in aerosols such as Freon.RTM. mixtures and is valuable in the treatment of respiratory diseases, particularly bronchial asthma and allergic rhinitis.
    Type: Grant
    Filed: September 14, 1981
    Date of Patent: June 12, 1990
    Assignee: Syntex Pharmaceuticals International Limited
    Inventors: Richard E. Jones, Gisela T. Haringer
  • Patent number: 4921657
    Abstract: The elastic modulus and density of an amorphous, ceramic article derived from a resinous organosilicon polymer and having a composition consisting essentially of silicon, nitrogen and/or carbon are increased while substantially maintaining or improving tensile strength by heat treating the ceramic article at an elevated temperature under superatmospheric nitrogen pressure to increase its density while avoiding crystallization. During heat treatment, at least some of the conditions of time, temperature, heating rate, cooling rate, pressure and atmosphere are controlled to minimize erosion of the article which could otherwise occur due to the loss to the surrounding atmosphere, as a gas or gaseous component, of at least one of nitrogen, silicon and carbon. The heat treated, ceramic article is amorphous and non-crystalline and has a density substantially greater than 2.5 g/cc together with desirable values of tensile strength and elastic modulus.
    Type: Grant
    Filed: November 13, 1987
    Date of Patent: May 1, 1990
    Assignee: Dow Corning Corporation
    Inventors: James A. Rabe, Jonathan Lipowitz, Richard E. Jones
  • Patent number: 4844140
    Abstract: A releasable drive assembly is described, suitable for use with a rolling door. The illustrated assembly comprises a chassis, a final drive unit rotatably mounted to the chassis for operating the door, a motor fixed with respect to the chassis, drive means interconnecting the motor with the final drive unit, the drive means including a clutch for releasing and re-engaging the motor and the final drive unit, the clutch including a slidable clutch unit keyed for rotation with one part of the drive means and having axially projecting formations respectively engageable and disengageable with mating formations on the other part of the drive means upon sliding movement of the clutch unit, latchable disengagement means for selective engagement with the slidable clutch unit for sliding the clutch unit into and out of engagement with the mating formations, the disengagement means being latchable to hold the clutch unit in its disengaged position.
    Type: Grant
    Filed: January 20, 1987
    Date of Patent: July 4, 1989
    Assignee: Byrne & Davidson Doors (N.S.W.) Pty. Limited
    Inventors: Richard E. Jones, Mitchell J. Billows
  • Patent number: 4831509
    Abstract: A door controller for roller type doors is disclosed incorporating a microprocessor control system. The microprocessor measures and stores the door speed over segments of the door travel to generate a door speed travel characteristic. This characteristic enables the door controller to accurately assess obstruction conditions by comparing a real time characteristic with a stored characteristic. The microprocessor also stores electronically the upper and lower limits of door travel. The microprocessor monitors electric motor duty cycle to avoid overheating of the motor and possible burnout while also controlling locking of the drive mechanism when the motor is inoperative. The microprocessor is also used to set the radio control signal code used to activate the door drive mechanism, the setting procedure allows for immediate verification of the set code.
    Type: Grant
    Filed: January 20, 1987
    Date of Patent: May 16, 1989
    Assignee: Byrne & Davidson Doors (N.S.W.)PTY. Limited
    Inventors: Richard E. Jones, Richard W. Aubert
  • Patent number: 4782887
    Abstract: A rolling door drive assembly including a chassis, a final drive unit rotatably mounted to the chassis for operating the door, a motor fixed with respect to the chassis, a drive device interconnecting the motor and the final drive unit, a housing defining a mounting channel on the assembly remote from the final drive unit, the mounting channel extending transversely to the axis of rotation of the final drive unit and adapted to receive part of a mounting bracket, and a mounting member extending into the mounting channel in a direction parallel to the axis for engagement with the mounting bracket.
    Type: Grant
    Filed: January 20, 1987
    Date of Patent: November 8, 1988
    Assignee: Byrne & Davidson Doors (N.S.W.) Pty. Limited
    Inventors: Richard E. Jones, Mitchell J. Billows
  • Patent number: D402078
    Type: Grant
    Filed: February 25, 1997
    Date of Patent: December 1, 1998
    Assignee: Philip Morris Incorporated
    Inventors: Grier Fleischhauer, Richard E. Jones